EQUITY ALERT: Rosen Law Firm Announces Investigation of Securities Claims Against Dynavax Technologies Corporation - DVAX
September 02 2016 - 6:25PM
Business Wire
Rosen Law Firm, a global investor rights law firm, announces it
is investigating potential securities claims on behalf of
shareholders of Dynavax Technologies Corporation (NASDAQ:DVAX)
resulting from allegations that Dynavax may have issued materially
misleading business information to the investing public.
On September 2, 2016, the U.S. Food and Drug Administration
(“FDA”) announced that it had cancelled Dynavax’s November 16, 2016
meeting with the Vaccines and Related Biological Products Advisory
Committee “to allow time for the FDA to review and resolve several
outstanding issues” with Dynavax’s Biologics License Application
for HEPLISAV-B™. The FDA further stated that it would schedule an
Advisory Committee meeting in the future if necessary. On this
news, shares of Dynavax dropped $5.03 or 32% from its previous
closing price to close at $10.91 on September 2, 2016.
Rosen Law Firm is preparing a class action lawsuit to recover
losses suffered by Dynavax investors. If you purchased shares of
Dynavax on or before September 2, 2016, please visit the firm’s
website at http://www.rosenlegal.com/cases-950.html for more
information. You may also contact Phillip Kim or Kevin Chan of
Rosen Law Firm toll free at 866-767-3653 or via email at
pkim@rosenlegal.com or kchan@rosenlegal.com.
Follow us for updates on LinkedIn:
https://www.linkedin.com/company/the-rosen-law-firm or on Twitter:
https://twitter.com/rosen_firm.
Rosen Law Firm represents investors throughout the globe,
concentrating its practice in securities class actions and
shareholder derivative litigation.
Attorney Advertising. Prior results do not guarantee a similar
outcome.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20160902005714/en/
Laurence Rosen, Esq.Phillip Kim, Esq.Kevin Chan, Esq.The Rosen
Law Firm, P.A.275 Madison Avenue, 34th FloorNew York, NY 10016Tel:
(212) 686-1060Toll Free: (866) 767-3653Fax: (212)
202-3827lrosen@rosenlegal.compkim@rosenlegal.comkchan@rosenlegal.comwww.rosenlegal.com
Dynavax Technologies (NASDAQ:DVAX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Dynavax Technologies (NASDAQ:DVAX)
Historical Stock Chart
From Apr 2023 to Apr 2024